header
Image from OpenLibrary

Evaluation of the Circulatory Mammary Cancer Stem Cells Enumeration in Monitoring and Prediction of Plasmonic Photothermal Therapy Antitumor Activity in Cats / Rasha Hamdy Abdelaziz Elsabagh ; Supervised Salah A. Selim , Eman R. M. Mostafa , Haithem A. M. Farghali

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Rasha Hamdy Abdelaziz Elsabagh, 2022Description: 148 P . : charts ; 25cmOther title:
  • تقييم تعداد خلايا ورم الضرع الجذعية الطرفية في المراقبة والتنبؤ بتأثير علاج البلازمون الضوئي الحراري المضاد للاورام في القطط [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Veterinary Medicine - Department of Microbiology Summary: Many studies have demonstrated the importance of Breast Cancer Stem Cells (BCSCs) with the phenotypes CD44+/CD24- and/or CD133+ in the initiation of invasive and metastatic mammary tumors. In felines, most of the queens with mammary carcinoma (MC) exhibited an aggressive metastatic tendency, that's why the developing of rapid, accurate and noninvasive technique for prediction and monitoring of metastasis in cats is important. Unlike conventional therapies, gold nanorods (AuNRs)-mediated plasmonic photothermal therapy (PPTT) selectively eliminates BCSCs. It is the first time in the current cohort study to: (1) detect and enumerate circulatory BCSCs in the feline peripheral blood against their specific cellular markers using flow cytometer analysis (FCA), (2) set up a cutoff value of diagnostic significance (>276 for CD44+/CD24- populations and >12 for CD133+ cells), and (3) investigate the anti-tumor activity of AuNRs PPTT on the circulatory BCSCs by FCA in cats with spontaneous metastatic and non-metastatic forms of MC. Our findings revealed statistically significant differences (p= 0.0001) between healthy and diseased animal groups, as well as a statistically significant (p= 0.046) increase in the CD44+/CD24- and CD133+ cell counts in cats with metastasis between baseline and last sample values. This supported the use of FCA as a sensitive, specific, and rapid diagnostic and monitoring tool for mammary carcinoma. As the PPTT was applied on each animal in this investigation either alone (Group AI &II) or in combination with mastectomy (Group B), the treated exhibited a gradual decrease in thetumor sizes till complete ablation 6-8 weeks post treatment. The total survival rate was 53.8%, the metastatic animals (Group AI) had a lower Overall Survival (OA) (17. months) and Progression Free Survival (PFS) (4.08 months) than the non-metastatic cats (22.5&19.3 months) respectively
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.10.10.Ph.D.2022.Ra.E (Browse shelf(Opens below)) Not for loan 01010110085651000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.10.10.Ph.D.2022.Ra.E (Browse shelf(Opens below)) 85651.CD Not for loan 01020110085651000

Thesis (Ph.D.) - Cairo University - Faculty of Veterinary Medicine - Department of Microbiology

Many studies have demonstrated the importance of Breast Cancer Stem Cells (BCSCs) with the phenotypes CD44+/CD24- and/or CD133+ in the initiation of invasive and metastatic mammary tumors. In felines, most of the queens with mammary carcinoma (MC) exhibited an aggressive metastatic tendency, that's why the developing of rapid, accurate and noninvasive technique for prediction and monitoring of metastasis in cats is important. Unlike conventional therapies, gold nanorods (AuNRs)-mediated plasmonic photothermal therapy (PPTT) selectively eliminates BCSCs. It is the first time in the current cohort study to: (1) detect and enumerate circulatory BCSCs in the feline peripheral blood against their specific cellular markers using flow cytometer analysis (FCA), (2) set up a cutoff value of diagnostic significance (>276 for CD44+/CD24- populations and >12 for CD133+ cells), and (3) investigate the anti-tumor activity of AuNRs PPTT on the circulatory BCSCs by FCA in cats with spontaneous metastatic and non-metastatic forms of MC. Our findings revealed statistically significant differences (p= 0.0001) between healthy and diseased animal groups, as well as a statistically significant (p= 0.046) increase in the CD44+/CD24- and CD133+ cell counts in cats with metastasis between baseline and last sample values. This supported the use of FCA as a sensitive, specific, and rapid diagnostic and monitoring tool for mammary carcinoma. As the PPTT was applied on each animal in this investigation either alone (Group AI &II) or in combination with mastectomy (Group B), the treated exhibited a gradual decrease in thetumor sizes till complete ablation 6-8 weeks post treatment. The total survival rate was 53.8%, the metastatic animals (Group AI) had a lower Overall Survival (OA) (17. months) and Progression Free Survival (PFS) (4.08 months) than the non-metastatic cats (22.5&19.3 months) respectively

Issued also as CD

There are no comments on this title.

to post a comment.